Theraclion SA
PAR:ALTHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Theraclion SA
Other Receivables
Theraclion SA
Other Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Theraclion SA
PAR:ALTHE
|
Other Receivables
€2m
|
CAGR 3-Years
2%
|
CAGR 5-Years
20%
|
CAGR 10-Years
10%
|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Other Receivables
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biomerieux SA
PAR:BIM
|
Other Receivables
€244.7m
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
5%
|
|
|
S
|
SMAIO SA
PAR:ALSMA
|
Other Receivables
€1.8m
|
CAGR 3-Years
27%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Other Receivables
€7.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Mauna Kea Technologies SA
PAR:ALMKT
|
Other Receivables
€1.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-4%
|
|
Theraclion SA
Glance View
Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
See Also
What is Theraclion SA's Other Receivables?
Other Receivables
2m
EUR
Based on the financial report for Jun 30, 2025, Theraclion SA's Other Receivables amounts to 2m EUR.
What is Theraclion SA's Other Receivables growth rate?
Other Receivables CAGR 10Y
10%
Over the last year, the Other Receivables growth was -9%. The average annual Other Receivables growth rates for Theraclion SA have been 2% over the past three years , 20% over the past five years , and 10% over the past ten years .
